Gold nanoparticle conjugated PLGA–PEG–SA–PEG–PLGA multiblock copolymer nanoparticles: synthesis, characterization, in vivo release of rifampicin
- 31 October 2013
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 2 (4) , 418-427
Abstract
A series of succinate linearly linked PLGA–PEG–SA–PEG–PLGA multiblock copolymers were synthesized using direct melt polycondensation and characterized using inherent viscosity, gel permeation chromatography (GPC), FTIR and 1H-NMR spectroscopy techniques. Gold nanoparticles (AuNPs) were synthesized using an as-synthesized citrate–PEG (CPEG) hybrid dendron, which acts as a reducing agent as well as a stabilizing agent. The CPEG capped AuNPs were characterized using UV–visible spectroscopy and TEM analysis. The Au-conjugated PLGA–PEG–SA–PEG–PLGA multiblock copolymer NPs were loaded with the tuberculosis drug rifampicin (RIF) using ultrasonication followed by solvent evaporation and were characterized by TEM, powder XRD and XPS analyses. The RIF loading efficiency and percentage drug content of RIF loaded Au-conjugated multiblock copolymer NPs were evaluated using UV–visible spectroscopy. The RIF loading efficiency and RIF content of the AuNP conjugated multiblock copolymer NPs were 41.8–75.7% and 11.5–17.7% respectively. The in vivo drug release studies in male Wistar rats show that AuNP conjugated multiblock copolymer NPs exhibit drug release up to 240 h. The nanoconjugates exhibit 18.13–29.41 μg mL−1 of Cmax with a delayed Tmax of 72 h and the relative bioavailability is increased to 107–190.Keywords
This publication has 41 references indexed in Scilit:
- Synthesis and characterization of pH-responsive and folated nanoparticles based on self-assembled brush-like PLGA/PEG/AEMA copolymer with targeted cancer therapy properties: A comprehensive kinetic studyEuropean Journal of Medicinal Chemistry, 2012
- Glucan Particle Encapsulated Rifampicin for Targeted Delivery to MacrophagesPolymers, 2010
- A bioequivalence comparison of two formulations of rifampicin (300- vs 150-mg capsules): An open-label, randomized, two-treatment, two-way crossover study in healthy volunteersClinical Therapeutics, 2010
- Surface deformation of gold nanorod-loaded poly(dl-lactide-co-glycolide) nanoparticles after near infrared irradiation: an active and controllable drug release systemJournal of Materials Chemistry, 2010
- In vitro release of rifampicin and biocompatibility of oleoylchitosan nanoparticlesJournal of Applied Polymer Science, 2008
- Gelatin microspheres of rifampicin cross-linked with sucrose using thermal gelation method for the treatment of tuberculosisJournal of Microencapsulation, 2008
- Highly Efficient Drug Delivery with Gold Nanoparticle Vectors for in Vivo Photodynamic Therapy of CancerJournal of the American Chemical Society, 2008
- Pharmacokinetics of RifampicinClinical Infectious Diseases, 2007
- Multiblock copolymers based on segments of poly (D,L-lactic-glycolic acid) and poly(ethylene glycol) or poly(?-caprolactone): A comparison of their thermal properties and degradation behaviorJournal of Applied Polymer Science, 2000
- Pharmacokinetics of Hydroflumethiazide during Repeated Administration in Congestive Heart FailureActa Pharmacologica et Toxicologica, 1982